Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Summit Therapeutics' HARMONi-6 Phase III Trial Shows Ivonescimab Plus Chemotherapy Significantly Improves PFS Over Tislelizumab In 1L Squamous NSCLC; Data To Be Presented At ESMO 2025 Presidential Symposium

Author: Benzinga Newsdesk | September 24, 2025 07:04am

Posted In: SMMT